Thursday, January 14, 2016

Cancer Is Focus Of Deals At JP Morgan Conference

Biotechnology: Acquisitions and collaborations target immuno-oncology and other cancer-fighting techniques

via Chemical & Engineering News: Biological SCENE http://ift.tt/1RHl8rK
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)